Douglas K. Rush

Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine.

Gina M. Bores, Francis P. Huger, Wayne W. Petko et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 248 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Scopolamine amnesia of passive avoidance: A deficit of information acquisition

Douglas K. Rush · Behavioral and Neural Biology · 1988 · 134 citations

Social Sciences, Neuroscience, Pharmacology +13

Nootropic drugs: Animal models for studying effects on cognition

Ursula Schindler, Douglas K. Rush, Simone Fielding · Drug Development Research · 1984 · 126 citations

Medicine, Neuroscience, Pharmacology +15

Intracerebral /sB-amyloid(25–35) produces tissue damage: Is it neurotoxic?

Douglas K. Rush, Suzann Aschmies, Michael C. Merriman · Neurobiology of Aging · 1992 · 73 citations

Medicine, Neurology, Neuroscience +12

The pharmacological profile of iloperidone, a novel atypical antipsychotic agent.

Mark R. Szewczak, Roy Corbett, Douglas K. Rush et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 60 citations

Medicine, Medicinal Chemistry, Pharmacology +16